Bioluminometric assay of ATP in mouse brain: Determinant factors for enhanced test sensitivity.
about
Alternate day fasting impacts the brain insulin-signaling pathway of young adult male C57BL/6 miceMetabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degenerationSynergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK.Low-level laser (light) therapy increases mitochondrial membrane potential and ATP synthesis in C2C12 myotubes with a peak response at 3-6 hHistone deacetylase HDAC4 promotes gastric cancer SGC-7901 cells progression via p21 repression.Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.Light-emitting diode therapy in exercise-trained mice increases muscle performance, cytochrome c oxidase activity, ATP and cell proliferationMuscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis.Proteolipid protein-deficient myelin promotes axonal mitochondrial dysfunction via altered metabolic coupling.Mitochondrial accumulation under oxidative stress is due to defects in autophagy.Light-emitting diode therapy in exercise-trained mice increases muscle performance, cytochrome c oxidase activity, ATP and cell proliferation [J. Biophotonics 8, No. 9, 740-754 (2015)].Bioelectrical impedance may predict cell viability during ischemia and reperfusion in rat liverAge-Related Changes in Axonal and Mitochondrial Ultrastructure and Function in White Matter.Histone deacetylase inhibitors preserve white matter structure and function during ischemia by conserving ATP and reducing excitotoxicity.Intracellular Assessment of ATP Levels in Caenorhabditis elegans.
P2860
Q28386794-5C9D90E2-F941-400A-96B0-10C855570425Q33907372-F20EE63E-ED32-4F33-91EA-1C3359B884C6Q34981610-0ABFD421-9568-4F3D-83F5-C95DD84D26DFQ35164032-B104B443-E59C-43E4-9987-77D1E0EDF921Q35181361-CF1E8CA1-FBAC-4F45-B10A-CA58C3CA9C29Q35193956-B8319937-8205-46A6-B7C4-7C01C17F57D5Q35577913-E767477F-544E-403A-83C7-4B8EFDF7A200Q35990359-013B9DD3-D789-4A9D-B037-C31C70144F97Q37429858-652F8FD4-7C3B-488F-BEC2-C26B5626B19BQ39295078-E00AD517-F643-438D-A97A-2E950EA142AAQ39424543-03C1493C-63AA-4256-8A22-F486FE39C380Q39772514-3A660518-C395-481F-A68D-1FB6D6240E11Q41200545-EFEA03AF-59E2-4211-BB4B-121514F667DFQ41763185-96D443ED-7094-4AFF-83F3-797A4EF51B1FQ42322205-70273B3A-466C-46C6-B430-96C108BAD878
P2860
Bioluminometric assay of ATP in mouse brain: Determinant factors for enhanced test sensitivity.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Bioluminometric assay of ATP i ...... for enhanced test sensitivity.
@en
Bioluminometric assay of ATP i ...... for enhanced test sensitivity.
@nl
type
label
Bioluminometric assay of ATP i ...... for enhanced test sensitivity.
@en
Bioluminometric assay of ATP i ...... for enhanced test sensitivity.
@nl
prefLabel
Bioluminometric assay of ATP i ...... for enhanced test sensitivity.
@en
Bioluminometric assay of ATP i ...... for enhanced test sensitivity.
@nl
P356
P1476
Bioluminometric assay of ATP i ...... for enhanced test sensitivity.
@en
P2888
P304
P356
10.1007/BF02705114
P577
2003-06-01T00:00:00Z